Why Figs Stock Popped Today
Figs (FIGS) stock rose 7.8% after Q3 earnings beat estimates, with revenue up 26% YoY to $190.7M and EPS at $0.10. Core scrubs sales grew 24%, while non-scrubwear and international sales saw faster growth. Profit margins expanded to 10.1%. CEO Trina Spear expects momentum into 2027, but Q4 growth forecast is slower at 15%.
How this was made

The 30-second read
Why it matters
The earnings beat provides a fresh catalyst for short-term buying, though cautious Q4 outlook may limit upside.
Market read
Earnings surprise creates immediate trading opportunity; sector peers may benefit from positive sentiment.
What to watch
International sales surge and new product lines may drive longer-term growth beyond the guidance.
Background
Figs, a medical scrubs supplier, reported Q3 results that beat estimates, prompting a sharp intraday rally.
Ticker impact
Q3 earnings beat revenue and EPS estimates, with sales up 26% YoY, driving a 7.8% intraday rally.
likely upward pressure as traders price in the earnings beat despite cautious guidance
Strong top-line growth and profit margin expansion are positive, while guidance slowdown introduces some caution.
Market effects
Highlights robust demand for medical apparel, potentially boosting peers in healthcare supplies.
U.S. healthcare sector may see modest uplift as investors reassess earnings expectations.
Limited to U.S. market; no broader macro implications.
Counterpoint
Guidance slowdown could signal a near-term earnings plateau, prompting profit-taking.
Key entities
- CompanyFigs
Medical apparel supplier listed on NYSE.


